Related Experiment Video
Updated: Aug 7, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation
1Department of Pharmacology, School of Medicine, University of Washington, Seattle, 98195, USA.
The EMBO Journal
|September 16, 2000
Summary
This study reveals a new pathway where phosphatidylinositol 3-kinase (PI3K) controls cell cycle entry. This PI3K pathway activates gene expression via SRF, crucial for growth factor-stimulated cell proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Phosphatidylinositol 3-kinase (PI3K) is recognized as a key regulator in cell division, programmed cell death, and cancer development.
- The precise mechanisms by which PI3K influences cell proliferation remain incompletely understood.
- Mitogens initiate the cell cycle by upregulating immediate early genes (IEGs), which subsequently drive the expression of G(1) cyclins.
Purpose of the Study:
- To elucidate the novel mechanisms by which PI3K regulates gene expression and cell cycle progression.
- To identify the role of PI3K in mitogen-induced expression of immediate early genes, specifically c-fos.
- To characterize a new transcriptional cascade regulated by PI3K.
Main Methods:
- Investigated PI3K's role in gene activation using reporter assays.
- Examined the involvement of Serum Response Factor (SRF)-dependent transcription.
- Utilized dominant-negative PI3K and SRF mutants to assess their impact on cell cycle progression.
- Assessed the effect of constitutively active SRF on cell cycle entry.
Main Results:
- Discovered a novel PI3K-regulated transcriptional cascade essential for mitogen control of the c-fos immediate early gene.
- Demonstrated that PI3K activates gene expression by transactivating SRF-dependent transcription, independent of Rho and ETS TCF pathways.
- Showed that PI3K-mediated cell cycle progression necessitates SRF transactivation, and dominant-negative PI3K inhibits mitogen-stimulated cell cycle entry.
- Found that dominant-interfering SRF mutants partially block mitogen-stimulated cell cycle progression but do not affect MEK-stimulated entry.
- Confirmed that expressing constitutively active SRF is sufficient to induce cell cycle entry.
Conclusions:
- A novel SRF-dependent mitogenic signaling cascade has been identified.
- This pathway is critical for both PI3K and growth factor-mediated cell cycle progression.
- The findings provide new insights into the molecular mechanisms governing cell proliferation.
More Related Videos
Related Concept Videos
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...